(PRESS RELEASE) VEVEY, 21-Dec-2020 — /EuropaWire/ — Nestlé Health Science Company, Aimmune Therapeutics announces that PALFORZIA® [defatted powder of Arachis hypogaea L., semen (peanuts)], has been approved by the European Commission for the treatment of peanut allergy in the European … Read the full press release
Posted in European Union, Food & Beverage, Healthcare, News, Pharma & Biotech, Switzerland
Tagged Aimmune Therapeutics, Andrew Oxtoby, ARTEMIS, EC, EU, European Commission, European Union, food allergies, Greg Behar, Nestlé Health Science, OIT, oral desensitization therapy, oral immunotherapy, PALFORZIA, PALISADE, peanut allergy, peanut protein, SwissMedic, treatment of peanut allergy
West Sussex, England, 9-9-2014 — /EuropaWire/ — Cereals such as wheat have long been considered a fundamental food source, yet growing numbers of people are intolerant to them and the list of wheat-related conditions seems to grow daily. Now, experts … Read the full press release
Posted in Food & Beverage, Healthcare, News, Science, United Kingdom
Tagged coeliac disease, digestive diseases, Dr Francesca Mangiola, food allergies, gastroenterology, gastrointestinal oncology and endoscopy, gliaden, Gluten, gluten-free diet, gluten-related disorders, glutenin, Intolerance, liver diseases, non-coeliac gluten sensitivity, Professor Antonio Gasbarrini, Professor Giovanni Gasbarrini, UEG, UEG Journal, UEG Week, United European Gastroenterology, Wheat, wheat allergy
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
